JOSEPH C. PAPA - 03 Sep 2024 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
MIST
Transactions as of
03 Sep 2024
Transactions value $
$0
Form type
4
Filing time
05 Sep 2024, 16:31:10 UTC
Previous filing
27 Jun 2024
Next filing
10 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIST Stock Option (right to buy) Award $0 +80K $0.00 80K 03 Sep 2024 Common Shares 80K $1.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest in equal monthly installments, beginning on October 3, 2024, over a period of three years, subject to the Reporting Person continuing to provide service through each such vesting date.